NCT00868660View on ClinicalTrials.gov

Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Inflammatory Bowel Disease
Interventions
DRUG

ZP1848

sc. bolus

Trial Locations (1)

08046

CRI Worldwide, Willingboro

Sponsors

Lead Sponsor

Zealand Pharma
All Listed Sponsors
lead

Zealand Pharma

INDUSTRY

NCT00868660 - Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose | Biotech Hunter | Biotech Hunter